This is in line with what was reported by Eisner et al. (24), who proposed the “thiazide challenge” test to discriminate between primary and secondary hyperparathyroidism in patients with recurrent kidney stones based on normalization of PTH levels after administration of hydrochlorotiazide 25 mg two times a day for 2 weeks. This evidence concerns the gene PTH and secondary hyperparathyroidism.